Gillian Munson Buys Shares of Phreesia, Inc. (PHR)

Gillian Munson purchased 19,290 shares of Phreesia, Inc. (NYSE: PHR) on June 24, 2026. The shares were bought at an average price of $9.59, bringing the total transaction value to about $184,991. This purchase was not made under a pre-arranged trading plan.

Insider Buying and Selling at Phreesia, Inc.

In addition to Gillian Munson, several other insiders also bought shares of Phreesia, Inc. on June 24, 2026. Lainie Goldstein, Mark Douglas Smith, Ramin Sayar, and Lisa Egbuonu-Davis each purchased 19,290 shares at the same price of $9.59. Lisa Egbuonu-Davis also sold 2,546 shares at $9.53 on June 25, 2026, under a planned transaction.

Other Institutional Activity in Phreesia, Inc.

Several institutional investors have recently adjusted their positions in Phreesia, Inc. Pale Fire Capital SE opened a new position with 8,649,329 shares valued at approximately $72.48 million. BlackRock, Inc. increased its holdings by 284,445 shares, ending with 5,920,469 shares worth about $49.61 million, marking a 5% increase. Vanguard Portfolio Management LLC also opened a new position with 3,335,121 shares valued at $27.95 million. AQR Capital Management LLC significantly boosted its stake by 1,415,465 shares, resulting in a 323.8% increase, bringing its total to 1,852,559 shares valued at $15.52 million.

Phreesia, Inc. Stock Down 24.9%

Shares of NYSE:PHR traded near $9.13 on Saturday. Phreesia, Inc. has a market capitalization of $622.4 million and a P/E ratio of 62.94. The stock's 52-week range is between $7.77 and $32.76, with a 50-day moving average of $9.38 and a 200-day moving average of $15.21. The company maintains a current ratio of 1.76 and a quick ratio of 1.43, with a debt-to-equity ratio of 25.78.

Analysts Set New Price Targets

On May 29, 2026, Truist Securities maintained its hold rating for Phreesia, Inc. with a price target of $12.00. Citigroup also maintained a hold rating with the same target on May 28, 2026. Canaccord Genuity and DA Davidson both maintained buy ratings with price targets of $16.00 and $14.00, respectively, on May 28, 2026. The consensus among analysts is a buy recommendation with a mean price target of $13.94 based on 17 opinions.

About Phreesia, Inc.

Phreesia, Inc. offers a software and payment platform for healthcare providers in the U.S. and Canada. Its services include appointment optimization, patient communications, and payment solutions. The company also provides digital tools like PhreesiaPads and Arrivals Kiosks for patient check-ins. Headquartered in Wilmington, Delaware, Phreesia employs around 1,789 people and is led by CEO Evan Roberts.

Bottom Line

Gillian Munson's recent purchase of Phreesia shares highlights ongoing interest in the healthcare technology company. With a market cap of $622.4 million and a diverse range of institutional investors, Phreesia remains a company to watch. Analyst ratings suggest a moderate upside, with a mean price target of $13.94. As always, note that insider transactions are disclosed after the fact and may not reflect current holdings.